{"database": "lobbying", "table": "lobbying_activities", "rows": [[1345392, "5dba645e-9c95-4d48-bf53-56f5501641ca", "Q4", "BAYER CORPORATION (CONSOLIDATED REPORT)", 5632, "BAYER CORPORATION (CONSOLIDATED REPORT)", 2012, "fourth_quarter", "PHA", "H.R. 4223 the \"Safe Doses Act\"; H.R. 3668 the \"Counterfeit Drug Penalty Enhancement Act of 2011\"; and H.R. 4216 the \"Foreign Counterfeit Prevention Act.\", all parts\nCombat Meth epidemic Act of 2005, sections pertaining to electronic reporting and stop sale\nMeth Lab Elimination Act of 2010, a draft by Sen. Wyden, all parts relating to pseudoephedrine", "HOUSE OF REPRESENTATIVES,SENATE", null, 1150000, 0, 0, "2013-01-18T15:42:17.393000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1345392"], "units": {}, "query_ms": 0.935619929805398, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}